|
New
Mikrogen: FSME / TBE Virus IgG and IgM ELISA for the detection of IgG and IgM antibodies against tick-borne encephalitis (TBE) virus in human serum, plasma or CSF. recomWell FSME / TBE Virus and recomWell Borrelia, the diagnosis of tick-borne diseases from a single source. Mikrogen: Bordetella pertussis IgG AND IgA Bordetella pertussis diagnostics standardized according to WHO: Our recomLine Bordetella pertussis assays have been standardized by the pertussis toxin standard recently provided by the WHO. Mikrogen: New version recomBlot Treponema 2.0 with new antigens I am pleased to announce the new version of recomBlot Treponema 2.0 IgG and IgM from Mikrogen. The new innovative antigens Tp257 and TP453 show high sensitivity and specificity during Treponema infection. SSI: New Products Statens Serum Institute has launched two new products: - Dermatophyte PCR for detection of fungi causing nail infection - E-coli O157 Latex test for rapid identification of E coli O157 antigens Euro-Diagnostica: Complement On the occasion of the forthcoming Complement Workshop in Basle we would like to introduce the Wieslab Complement Elisa from Euro-Diagnostica, Sweden. Herewith we can offer you a unique diagnostic concept for complement activity analysis for classical, MBL and alternative pathways. Elisa kits for assessment of Complement activity are available as one kit for each pathway or as a combikit. EURCOMPL 300 | Elisa Complement System Combikit | 96 wells | EURCOMPL CP310 | Elisa Classical Pathway | 96 wells | EURCOMPL MP320 | Elisa MBL Pathway | 96 wells | EURCOMPL AP330 | Elisa Alternative Pathway | 96 wells |
Cellestis: QuantiFERON We are pleased to announce that you can buy the QuantiFERON products in Switzerland from Pharma Consulting. Please do not hesitate to ask us for the conditions.
Mikrogen: recomLine Parvovirus B19 IgG and IgM We are pleased to announce the newly developed testsystem recomLine Parvovirus B19. The recomLine Parvovirus B19 is a qualitative in-vitro-test for the detection of IgG- and IgM- antibodies against proteins of Parvovirus B19 in human sera and plasma. It provides for identification of specific Parvovirus B19 antibodies by means of seperate line-ups of different antigens, produced by recombinant engineering. In contrast to ELISA testing systems the recomLine Parvovirus B19 gives additional information about the state of infection by different reactivity patterns and the determination of avidity. Mikrogen: recomLine Borrelia IgG and IgM We are pleased to announce the highly innovative recomLine Borrelia IgG and recomLine Borrelia IgM. This test system for the first time contains single antigen bands against B. spielmanii, the 4th known pathogenic Borrelia species. Advantages: Recombinant antigens: high sensitivity and specificity Immunodominant antigens of the four genospecies: B. burgdorferi sensu stricto, B. garinii, B. afzelii and B. spielmanii Easy test procedure; automation possible Easy and objective evaluation and documentation by recomScan software Test procedure and reagents identical in all MIKROGEN strip tests - reagents exchangeable Separate detection of IgG and IgM antibodies Safe evaluation due to strip specific controls (cut-off and conjugate control) Standardised serum-liquor-analysis available Complement as confirmation tests ideally the recomWell Borrelia tests (ELISA) CE label Conform with MIQ 12/2000 and DIN 58969-44
|
